Pertussis vaccination coverage among adults in Germany;Pertussis-Impfquoten bei Erwachsenen in Deutschland

Deutsche Medizinische Wochenschrift

Volumn 138, Issue 28-29, 2013, Pages 1451-1457

  Bohmer M M ^a,c   Hellenbrand, W ^a   Matysiak Klose, D ^a   Heininger, U ^b   Muters S ^a   Wichmann, O ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

coverage; pertussis; vaccination; whooping cough

Indexed keywords

PERTUSSIS VACCINE; TETANUS TOXOID;

ADULT; ARTICLE; DISEASE CONTROL; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; VACCINATION;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEALTH PROMOTION; HEALTH SURVEYS; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; MALE; MIDDLE AGED; PERTUSSIS VACCINE; UTILIZATION REVIEW; WHOOPING COUGH; YOUNG ADULT;

EID: 84879956099     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0033-1343249     Document Type: Article

References (31)

1. American Association for Public Opinion Research (AAPOR) Standard Definitions - Final Dispositions of Case Codes and Outcome Rates for Surveys. 2011; http://www.aapor.org/AM/Template.cfm?Section=Standard- Definitions2&Template=/CM/ContentDisplay.cfm&ContentID=3156 (letzter Zugriff: 27.05.2013)
2. Beytout J., Launay O., Guiso N. et al. Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial. Hum Vaccin: 2009; 5 315 321
3. Böhmer M. M., Walter D., Krause G. et al. Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany. Hum Vaccin: 2011; 7 1317 1325
4. Böhmer M. M., Walter D., Müters S. et al. Seasonal influenza vaccine uptake in Germany 2007/2008 and 2008/2009: results from a national health update survey. Vaccine: 2011; 29 4492 4498
5. Centers for Disease Control and Prevention Risk Factor Surveillance System: 2009 Summary Data Quality Report. 2011; ftp://ftp.cdc.gov/pub/Data/ Brfss/2009-Summary-Data-Quality-Report.pdf (letzter Zugriff: 27.05.2013)
6. David S. T., Hemsley C., Pasquali P. E. et al. Enhanced surveillance for vaccine-associated adverse events: dTap catch-up of high school students in Yukon. Can Commun Dis Rep: 2005; 31 117 126
7. De Serres G., Shadmani R., Duval B. et al. Morbidity of pertussis in adolescents and adults. J Infect Dis: 2000; 182 174 179
8. Greenberg D. P., von Konig C. H., Heininger U. Health burden of pertussis in infants and children. Pediatr Infect Dis J: 2005; 24 01 S39 S43
9. Halperin S. A., Sweet L., Baxendale D. et al. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Pediatr Infect Dis J: 2006; 25 195 200
10. Heininger U., Klich K., Stehr K. et al. Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics: 1997; 100 E10
11. Heininger U., Stehr K., Christenson P. et al. Evidence of efficacy of the Lederle/Takeda acellular pertussis diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. Clin Infect Dis: 1999; 28 602 604
12. Robert Koch-Institut Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2012. Epidemiologisches Bulletin: 2012; 30 283 310
13. Kurth B. M., Lange C., Kamtsiuris P. et al. Gesundheitsmonitoring am Robert Koch-Institut. Sachstand und Perspektiven. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz: 2009; 52 557 570
14. Lampert T., Kroll L. E., Müters S. et al. Messung des sozioökonomischen Status in der Studie "Gesundheit in Deutschland aktuell" (GEDA). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz: 2013; 56 131 143
15. Lavine J., Broutin H., Harvill E. T. et al. Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine: 2010; 29 11 16
16. Lavine J. S., Bjornstad O. N., de Blasio B. F. et al. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine: 2012; 30 544 551
17. Postels-Multani S., Schmitt H. J., Wirsing von König C. H. et al. Symptoms and complications of pertussis in adults. Infection: 1995; 23 139 142
18. Robert Koch-Institut Impfempfehlungen der Ständigen Impfkommission (STIKO) am Rober Koch-Institut/Stand: Juli 2001. Epidemiologisches Bulletin: 2001; 28 203 215
19. Robert Koch-Institut Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut / Stand: Juli 2004. Epidemiologisches Bulletin: 2004; 30 235 250
20. Robert Koch-Institut Zusätzliche Pertussis-Impfung im Erwachsenenalter als Tdap-Kombinationsimpfung bei der nächsten fälligen Td-Impfung - Empfehlung und Begründung. Epidemiologisches Bulletin: 2009; 31 299 311
21. Robert Koch-Institut Keuchhusten-Erkrankungen in den neuen Bundesländern seit 2007. Epidemiologisches Bulletin: 2010; 47 463 471
22. Robert Koch-Institut Daten und Fakten: Ergebnisse der Studie "Gesundheit in Deutschland aktuell 2010" Berlin RKI: 2012
23. Rothstein E., Edwards K. Health burden of pertussis in adolescents and adults. The Pediatr Infect Dis J: 2005; 24 44 47
24. Stojanov S., Liese J., Belohradsky B. H. Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection. Infection: 2000; 28 106 110
25. von Konig C. H., Halperin S., Riffelmann M. et al. Pertussis of adults and infants. Lancet Infect Dis: 2002; 2 744 750
26. Wendelboe A. M., Njamkepo E., Bourillon A. et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J: 2007; 26 293 299
27. Wendelboe A. M., Van Rie A., Salmaso S. et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J: 2005; 24 58 61
28. Wiese-Posselt M., Leitmeyer K., Hamouda O. et al. Influenza vaccination coverage in adults belonging to defined target groups, Germany, 2003/2004. Vaccine: 2006; 24 2560 2566
29. World Health Oranization Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec: 2010; 85 385 400
30. Zhang L., Prietsch S. O., Axelsson I. et al. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev: 2012; 3 CD001478
31. Zhang X., Rodriguez M. E., Harvill E. T. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PloS One: 2009; 4 e6989